HealthQuill COVID-19
Mosquitoes by the evening. Image Credit: Wolfgang Hasselmann on Unsplash
Climate Drugs Pharma

WHO global malaria strategy ‘off track by a wide margin’

HQ Team November 30, 2023: The Covid-19 pandemic significantly disrupted malaria services, leading to a surge in both incidence and mortality rates, exacerbating.

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More
One in seven people in the US has had long Covid by the end of 2022, according to a study by British and American researchers.
Drugs Health Pharma

One in seven people in US reports having long Covid by the end of 2022

HQ Team November 6, 2023: One in seven people in the US has had long Covid by the end of 2022, according to.

Read More
Germany's  BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty vaccine may impact 2023 revenue of up to $900 million.
Drugs Health Pharma

BioNTech expects revenue to be lower in 2023 as Covid-19 vaccine sales fall

HQ Team October 16, 2023: Germany’s  BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.

Read More
The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12 years of age or above, the regulator announced.
Drugs Health Pharma

Novavax gets FDA nod for updated Covid-19 vaccine for 12 years and above

HQ Team October 4, 2023: The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12.

Read More
The WHO has recommended Japanese drugmaker Takeda Pharmaceutical Co’s Qdenga vaccine for dengue where there is a high disease burden and high transmission intensity.
Drugs Health Pharma

Global health agency recommends Takeda’s dengue vaccine Qdenga 

HQ Team October 3, 2023: The WHO has recommended Japanese drugmaker Takeda Pharmaceutical Co’s Qdenga vaccine for dengue where there is a high.

Read More
Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine for their discoveries that led to the development of vaccines to fight the Covid-19 virus.
Drugs Health Pharma

Scientists behind Covid-19 mRNA vaccine bag Nobel medicine prize

HQ Team October 2, 2023: Hungarian-born biochemist Katalin Kariko and US immunologist Drew Weissman jointly won the Nobel Prize in Physiology or Medicine.

Read More
A total of 770,875,433 (770.8 million) people globally have been infected by the coronavirus as of September 27 and 6,959,316 died due to the disease, according to the WHO.
Drugs Health Pharma

COVID-19 global death toll nears seven million, WHO says ‘still a threat’ 

HQ Team October 2, 2023: A total of 770,875,433 (770.8 million) people globally have been infected by the coronavirus as of September 27.

Read More
DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of an antigen-based vaccine candidate to treat all coronaviruses.
Drugs Health Pharma

DIOSynVax to finish coronavirus vaccine trial in humans by month-end

HQ Team September 29, 2023: DIOSynVax, a spin-out company of the University of Cambridge, is in its final stage of human trials of.

Read More
The Central Intelligence Agency offered bribes to six analysts to change their position on COVID-19’s origins from a lab leak theory in China to zoonotic origins, according to the Select Subcommittee on Corona Pandemic, — an allegation which CIA rejected.
Drugs Health Pharma

CIA paid analysts to change sides on COVID-19 origins: Whistleblower

The Central Intelligence Agency offered bribes to six analysts to change their position on COVID-19’s origins from a lab leak theory in China.

Read More